These press releases are intended for business journalists and analysts/investors
Professor Brendan Crabb wins 2019 GSK Award for Research Excellence
“There is probably no more impactful contribution to human development than ridding the world of malaria,” says winner
GlaxoSmithKline Australia (GSK), in consultation with the Therapeutic Goods Administration, would like to provide the following information to ensure that there is no confusion in relation to the expiration date of measles, mumps and rubella vaccine (MMR), Priorix.
Andrew Jenkin has been appointed General Manager GSK Consumer Healthcare, ANZ. The appointment comes after GSK and Pfizer closed the transaction to create a new consumer healthcare Joint Venture yesterday.
Read more - Andrew Jenkin to Lead new GSK Consumer Healthcare Joint Venture in ANZ Read more
ARNUITY ELLIPTA (fluticasone furoate), once-daily maintenance therapy for asthma reimbursed by the PBS in Australia
Read more - New once-daily treatment option reimbursed for patients with asthma Read more
Australia’s National Immunisation Program (NIP) is one of the world’s best, achieving some of the highest vaccination rates in the world and supporting community protection against a wide range of vaccine preventable diseases. However, Australia’s timely access to life saving vaccines is under increasing challenge, as the system that assesses which vaccines are included on the NIP falls behind other countries on some issues and may not always match with how the community values prevention.
Read more - GSK statement on ACCC Federal Court judgment Read more
Read more - GSK Australia reports 2018 results to ASIC Read more
Read more - 2019 GSK Award for Research Excellence open for nominations Read more
